Mouse Anti Human Macrophage (Tissue And Proliferative Disorders) Monoclonal Antibody |
|
DMABT-52185MH |
Creative Diagnostics |
0.5 ml |
EUR 1226.4 |
Human IgG antibody Laboratories manufactures the nervous system disorders of monoclonal igm reagents distributed by Genprice. The Nervous System Disorders Of Monoclonal Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Nervous products are available in stock. Specificity: Nervous Category: System Group: Disorders Of
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Erythropoietin (EPO) (Marker of Placentation Disorders) |
|
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Disorders Of information
SULT4A1 (sulfotransferase family 4A, Member 1, Brain sulfotransferase-like protein, Nervous system sulfotransferase, brain sulphotransferase-like, nervous system cytosolic sulfotransferase, sulfotransferase-related protein) |
|
MBS647252-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3560 |
SULT4A1 (sulfotransferase family 4A, Member 1, Brain sulfotransferase-like protein, Nervous system sulfotransferase, brain sulphotransferase-like, nervous system cytosolic sulfotransferase, sulfotransferase-related protein) |
|
MBS622667-01mg |
MyBiosource |
0.1mg |
EUR 905 |
SULT4A1 (sulfotransferase family 4A, Member 1, Brain sulfotransferase-like protein, Nervous system sulfotransferase, brain sulphotransferase-like, nervous system cytosolic sulfotransferase, sulfotransferase-related protein) |
|
MBS622667-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3925 |
Nna1 (Nervous system nuclear protein induced by axotomy 1, AGTPBP1, Cytosolic carboxypeptidase-1) |
|
MBS619079-01mL |
MyBiosource |
0.1mL |
EUR 660 |
Nna1 (Nervous system nuclear protein induced by axotomy 1, AGTPBP1, Cytosolic carboxypeptidase-1) |
|
MBS619079-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2810 |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF647 conjugate, 0.1mg/mL |
|
BNC473792-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF647 conjugate, 0.1mg/mL |
|
BNC473792-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF647 conjugate, 0.1mg/mL |
|
BNC473793-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF647 conjugate, 0.1mg/mL |
|
BNC473793-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF568 conjugate, 0.1mg/mL |
|
BNC683792-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF568 conjugate, 0.1mg/mL |
|
BNC683792-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF568 conjugate, 0.1mg/mL |
|
BNC683793-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF568 conjugate, 0.1mg/mL |
|
BNC683793-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF594 conjugate, 0.1mg/mL |
|
BNC943792-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF594 conjugate, 0.1mg/mL |
|
BNC943792-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL |
|
BNC943793-100 |
Biotium |
1uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL |
|
BNC943793-500 |
Biotium |
1uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
